Porphobilinogen Qualitative Urine (PBG Urine) Test
Blood Sample
Free Home Collection
Digital Smart Report
Recommended for Male/Female
NABL & CAP Certified Labs
Trusted by Leading Doctors & Organizations
About Porphobilinogen (Qualitative) - Urine (Random)
Porphobilinogen (PBG) is a precursor in the heme biosynthesis pathway. A qualitative urine test for PBG is used to detect elevated levels of porphobilinogen, which may indicate acute porphyria, a group of rare metabolic disorders affecting heme production.
Porphyria refers to a group of rare genetic or acquired disorders caused by abnormalities in the production of heme, a vital component of hemoglobin. These disorders result from enzyme deficiencies in the heme biosynthesis pathway, leading to the buildup of porphyrins or their precursors, which can be toxic to the body.
Porphyria can be acute or cutaneous.
Acute Porphyrias affect the nervous system and can cause severe abdominal pain, vomiting, seizures, muscle weakness, and psychiatric symptoms. Examples include Acute Intermittent Porphyria (AIP), Variegate Porphyria (VP), Hereditary Coproporphyria (HCP).
Cutaneous Porphyrias affect the skin, leading to photosensitivity, blistering, and chronic skin damage upon sun exposure. Examples include Porphyria Cutanea Tarda (PCT), Erythropoietic Protoporphyria (EPP).
What is the Porphobilinogen (Qualitative) - Urine Test Used For?
The test is primarily used to:
- Screen for acute intermittent porphyria (AIP) and other acute porphyrias.
- Identify episodes of acute porphyria in symptomatic individuals.
- Differentiate porphyria from other conditions causing neurological or gastrointestinal symptoms
Symptoms of Acute Porphyria
Individuals undergoing acute porphyria attacks may experience
Preparation for the Test
No special preparation is required. A random urine sample is collected in a clean container. Avoid exposure to light, as PBG is light-sensitive. The sample should be refrigerated or protected from light immediately after collection
Interpretation of the Test Results
Negative: No detectable levels of porphobilinogen, indicating no acute porphyria.
Positive: Presence of porphobilinogen, which suggests a possible acute porphyria attack. Further confirmatory tests, such as quantitative PBG testing and genetic analysis, may be required
FAQs on Porphobilinogen (Qualitative) - Urine (Random)
A single urine sample is collected in a sterile container and should be kept away from light until tested
Acute intermittent porphyria (AIP), variegate porphyria (VP), and hereditary coproporphyria (HCP) are the primary causes of elevated PBG levels
Yes, certain drugs like barbiturates, sulfonamides, and anticonvulsants can induce porphyria symptoms and affect test results
Results are typically available within 1–3 days, depending on the laboratory
A quantitative PBG test, genetic testing, and additional biochemical assays may be recommended to confirm the diagnosis
Severe abdominal pain
Nausea and vomiting
Neurological symptoms, including confusion, seizures, and muscle weakness
Dark or reddish-colored urine
Tachycardia (rapid heartbeat)
High blood pressure
